DE69832688D1 - Hochselektive butyrylcholinesterase inhibitoren zur behandlung und zur diagnose von demenz und alzheimers krankheit - Google Patents
Hochselektive butyrylcholinesterase inhibitoren zur behandlung und zur diagnose von demenz und alzheimers krankheitInfo
- Publication number
- DE69832688D1 DE69832688D1 DE69832688T DE69832688T DE69832688D1 DE 69832688 D1 DE69832688 D1 DE 69832688D1 DE 69832688 T DE69832688 T DE 69832688T DE 69832688 T DE69832688 T DE 69832688T DE 69832688 D1 DE69832688 D1 DE 69832688D1
- Authority
- DE
- Germany
- Prior art keywords
- alzheimers
- dementia
- illness
- diagnosis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5208797P | 1997-07-09 | 1997-07-09 | |
US52087P | 1997-07-09 | ||
PCT/US1998/014063 WO1999002154A1 (en) | 1997-07-09 | 1998-07-09 | Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69832688D1 true DE69832688D1 (de) | 2006-01-12 |
DE69832688T2 DE69832688T2 (de) | 2006-09-07 |
Family
ID=21975382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69832688T Expired - Lifetime DE69832688T2 (de) | 1997-07-09 | 1998-07-09 | Hochselektive butyrylcholinesterase inhibitoren zur behandlung und zur diagnose von demenz und alzheimers krankheit |
Country Status (17)
Country | Link |
---|---|
US (2) | US6410747B1 (de) |
EP (1) | EP0949920B1 (de) |
JP (1) | JP4522499B2 (de) |
AT (1) | ATE311876T1 (de) |
AU (1) | AU749088C (de) |
BR (1) | BR9806184A (de) |
CA (1) | CA2264750C (de) |
CZ (1) | CZ297533B6 (de) |
DE (1) | DE69832688T2 (de) |
DK (1) | DK0949920T3 (de) |
ES (1) | ES2255170T3 (de) |
HU (1) | HUP0003852A3 (de) |
IL (2) | IL128877A0 (de) |
MX (1) | MXPA04001462A (de) |
PL (1) | PL191402B1 (de) |
SI (1) | SI0949920T1 (de) |
WO (1) | WO1999002154A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6488280B1 (en) * | 2000-09-27 | 2002-12-03 | Milestone Entertainment | Games, and methods and apparatus for game play in games of chance |
EP1349858B1 (de) * | 2000-11-02 | 2008-08-27 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Wirkstoffe für die verminderung von amyloid precursor protein und die behandlung von schwachsinn, und deren verfahren der verwendung |
CN1898201A (zh) * | 2003-10-21 | 2007-01-17 | 森蒂有限公司 | 可抑制胆碱酯酶和释放药理学活性试剂的氨基甲酸酯 |
EP1718294A4 (de) * | 2004-01-30 | 2007-10-03 | Axonyx Inc | Verfahren zur behandlung von diabetischen komplikationen |
US20050182044A1 (en) * | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
WO2005123068A2 (en) * | 2004-06-08 | 2005-12-29 | Axonyx, Inc. | Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor |
WO2006004201A1 (ja) * | 2004-07-01 | 2006-01-12 | Eisai R & D Management Co., Ltd. | 神経再生促進剤 |
US20060105940A1 (en) * | 2004-11-03 | 2006-05-18 | Axonyx, Inc. | Compound useful in the treatment or prevention of cognitive disorders associated with diabetes and associated methods |
US20060194723A1 (en) * | 2005-02-28 | 2006-08-31 | Rabinoff Michael D | Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement |
KR100701798B1 (ko) | 2005-05-04 | 2007-03-30 | 라이브켐 주식회사 | 해조식물로부터 추출한 콜린에스터라제 활성 억제제를함유하는 알츠하이머성 치매 개선제 및 인지능력 개선제 |
US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
US20070167509A1 (en) * | 2005-06-14 | 2007-07-19 | Joseph Araujo | Use of phenserine and analogs to treat behavioral problems and improve trainability |
US20100069337A1 (en) * | 2006-10-31 | 2010-03-18 | Acey Roger A | Butyrylcholinesterase inhibitors |
US9757399B2 (en) | 2006-10-31 | 2017-09-12 | Jal Therapeutics, Inc. | Butyrylcholinesterase inhibitors |
US20090048229A1 (en) * | 2007-07-18 | 2009-02-19 | Rupniak Nadia M J | Methods for promoting wakefulness |
AU2009229372C1 (en) | 2008-03-27 | 2017-02-02 | Chase Pharmaceuticals Corporation | Use and composition for treating dementia |
NZ591824A (en) | 2008-08-29 | 2013-07-26 | Treventis Corp | Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system |
WO2010067594A1 (ja) * | 2008-12-11 | 2010-06-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘキサヒドロピロロインドール誘導体 |
US8892184B2 (en) | 2010-10-18 | 2014-11-18 | Siemens Medical Solutions Usa, Inc. | Systems and methods for reducing interference in a dual modality imaging system |
US20120225922A1 (en) | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
IN2015DN01706A (de) | 2012-09-05 | 2015-05-22 | Chase Pharmaceuticals Corp | |
KR101667215B1 (ko) | 2014-10-21 | 2016-10-18 | 한밭대학교 산학협력단 | 신규한 트립타민 컨쥬게이트 화합물 및 그의 용도 |
EP3242659A4 (de) | 2015-01-09 | 2018-09-12 | Chase Pharmaceuticals Corporation | Transdermale oxybutynintherapiesystemkombination |
CA3083015A1 (en) | 2017-05-24 | 2018-11-28 | Qr Pharma, Inc. | Prevention or treatment of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humans |
CN109535157B (zh) * | 2018-12-03 | 2021-10-15 | 江苏科技大学 | 一种半蜡梅碱类似物、其合成方法及其用途 |
KR102233120B1 (ko) | 2018-12-18 | 2021-03-29 | 한밭대학교 산학협력단 | 신규한 파에오놀-트립타민 화합물 및 그의 용도 |
EP4087847A4 (de) * | 2020-01-10 | 2024-02-28 | The Regents of the University of California | Zusammensetzungen und verfahren zur behandlung von neurodegenerativen erkrankungen |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
US4900748A (en) * | 1988-03-04 | 1990-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Carbamates related to (-)-physostigmine as cholinergic agents |
US5171750A (en) * | 1991-09-26 | 1992-12-15 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted phenserines as specific inhibitors of acetylcholinesterase |
CA2119782C (en) * | 1991-09-26 | 2005-08-23 | Arnold Brossi | Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases |
DE69233093T2 (de) * | 1991-09-26 | 2003-12-18 | Us Gov Health & Human Serv | Substituierte phenserine und phenylcarbamate von (-)-eserolin, (-)-n1-noreserolin und (-)-n1-benzylnoresorolin als spezifische acetylcholinesterase-inhibitoren |
US5409948A (en) * | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
US5783584A (en) * | 1995-12-11 | 1998-07-21 | Mayo Foundation For Medical Education And Research | THA analogs useful as cholinesterase inhibitors |
EP1603365A1 (de) * | 2002-03-12 | 2005-12-07 | Matsushita Electric Industrial Co., Ltd. | Hochfrequenzheizvorrichtung und Steuerungsverfahren derselben. |
-
1998
- 1998-07-09 US US09/254,494 patent/US6410747B1/en not_active Expired - Lifetime
- 1998-07-09 AT AT98933230T patent/ATE311876T1/de not_active IP Right Cessation
- 1998-07-09 AU AU82931/98A patent/AU749088C/en not_active Ceased
- 1998-07-09 DE DE69832688T patent/DE69832688T2/de not_active Expired - Lifetime
- 1998-07-09 CA CA002264750A patent/CA2264750C/en not_active Expired - Fee Related
- 1998-07-09 DK DK98933230T patent/DK0949920T3/da active
- 1998-07-09 MX MXPA04001462A patent/MXPA04001462A/es unknown
- 1998-07-09 ES ES98933230T patent/ES2255170T3/es not_active Expired - Lifetime
- 1998-07-09 JP JP50884999A patent/JP4522499B2/ja not_active Expired - Fee Related
- 1998-07-09 SI SI9830820T patent/SI0949920T1/sl unknown
- 1998-07-09 EP EP98933230A patent/EP0949920B1/de not_active Expired - Lifetime
- 1998-07-09 HU HU0003852A patent/HUP0003852A3/hu unknown
- 1998-07-09 BR BR9806184-4A patent/BR9806184A/pt active Search and Examination
- 1998-07-09 IL IL12887798A patent/IL128877A0/xx active IP Right Grant
- 1998-07-09 PL PL332078A patent/PL191402B1/pl unknown
- 1998-07-09 CZ CZ0081699A patent/CZ297533B6/cs not_active IP Right Cessation
- 1998-07-09 WO PCT/US1998/014063 patent/WO1999002154A1/en active IP Right Grant
-
1999
- 1999-03-08 IL IL128877A patent/IL128877A/en not_active IP Right Cessation
-
2002
- 2002-02-07 US US10/071,488 patent/US6683105B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PL191402B1 (pl) | 2006-05-31 |
CA2264750C (en) | 2009-06-16 |
HUP0003852A3 (en) | 2003-04-28 |
DK0949920T3 (da) | 2006-04-18 |
IL128877A (en) | 2007-10-31 |
AU8293198A (en) | 1999-02-08 |
SI0949920T1 (sl) | 2006-10-31 |
HUP0003852A2 (hu) | 2001-04-28 |
US20020094999A1 (en) | 2002-07-18 |
PL332078A1 (en) | 1999-08-30 |
AU749088B2 (en) | 2002-06-20 |
CZ81699A3 (cs) | 2000-01-12 |
WO1999002154A1 (en) | 1999-01-21 |
JP2001500165A (ja) | 2001-01-09 |
DE69832688T2 (de) | 2006-09-07 |
CZ297533B6 (cs) | 2007-01-03 |
ATE311876T1 (de) | 2005-12-15 |
BR9806184A (pt) | 2001-06-19 |
EP0949920B1 (de) | 2005-12-07 |
US6410747B1 (en) | 2002-06-25 |
US6683105B2 (en) | 2004-01-27 |
ES2255170T3 (es) | 2006-06-16 |
CA2264750A1 (en) | 1999-01-21 |
JP4522499B2 (ja) | 2010-08-11 |
AU749088C (en) | 2005-11-03 |
MXPA04001462A (es) | 2005-04-29 |
IL128877A0 (en) | 2000-01-31 |
EP0949920A1 (de) | 1999-10-20 |
EP0949920A4 (de) | 2003-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69832688D1 (de) | Hochselektive butyrylcholinesterase inhibitoren zur behandlung und zur diagnose von demenz und alzheimers krankheit | |
DE69429369T2 (de) | Verfahren und mittel zur behandlung abnormaler zustände des epitheliums von körperöffnungen | |
ATE275383T1 (de) | Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen | |
DE69725339D1 (de) | Vorrichtung zur diagnose und behandlung von arrhythmien | |
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE69829921D1 (de) | Vorrichtung zur Behandlung von Körpergewebe | |
DE69934112D1 (de) | Implantierbarer gewebeverschluss und system zur behandlung gastroösophagischen rückflusses | |
DE69631613D1 (de) | Mit Verriegelungsmechanismus versehene Vorrichtung zur chirurgischen Behandlung von Gewebe | |
DE69739303D1 (de) | Vorrichtung zur thermischen behandlung von gewebe | |
DE69636674D1 (de) | Vorrichtung zur wärmebehandlung von gewebe | |
DE69836752D1 (de) | Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen | |
DE69625691T2 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
DE69805973T2 (de) | Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase | |
DE69827424D1 (de) | Vorrichtung zur gesteuerten thermischen Behandlung von Gewebe | |
ATE262336T1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
ATE271038T1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
DE69620306D1 (de) | 4-(.Alpha.-hydroxy-.alpha.-aryl-alkylcarbonylamino)-Piperidine zur Behandlung und Prophylaxe von Erkrankungen der Harnwege | |
DE69711311D1 (de) | Vorrichtung zur thermischen Behandlung von Gewebe | |
DE69630321D1 (de) | Vorrichtung zur örtlichen wärmebehandlung von gewebe | |
ATE201992T1 (de) | Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen | |
DE69925488D1 (de) | Verwendung von fk506 und verwandten makroliden zur herstellung eines medikaments für die behandlung und vorbeugung von schmerzen | |
DE50012013D1 (de) | Verfahren und Vorrichtung zur Begrenzung des Drehmomentes zahnärztlicher und chirurgischer Handstücke | |
DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
DE69829217D1 (de) | Vorrichtung zur therapeutischen behandlung von blutgefässen | |
DE69936994D1 (de) | Verfahren zur behandlung von okularen neovaskularen erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |